安科生物(300009.SZ):擬推第3期員工持股計劃 資金總額不超1131.375萬元
格隆匯3月27日丨安科生物(300009.SZ)公佈第3期員工持股計劃(草案),本持股計劃設立時計劃份額不超過11,313,750份(含本數),每計劃份額的認購價格爲人民幣1.00元,資金總額不超過1131.3750萬元(含本數),具體金額根據員工實際繳款金額確定。
本持股計劃受讓的股份總數合計不超過129.3萬股,佔公司目前股份總數1,672,553,658股的0.0773%。
本持股計劃的參與對象爲公司及下屬控股子公司簽訂勞動合同或聘用合同的創新研發團隊的核心管理人員及技術骨幹,總人數不超過9人,不涉及公司董事、監事及高級管理人員,公司實際控制人、控股股東、持有公司股份5%以上的股東及其近親屬也未參與本持股計劃。
本持股計劃的存續期爲36個月,自公司公告最後一筆標的股票過戶至本持股計劃名下之日起算,其中前12個月爲鎖定期,後24個月爲解鎖期。一旦本持股計劃所持有的公司股票全部出售,本計劃可提前終止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.